By: News 9 Stitt signed House Bill 1019 into law on Tuesday. HB 1019 will cap the cost of insulin for a 30-day supply to $30 and for a 90-day supply to $90. It will also give the Oklahoma Insurance Commissioner authority to enforce the price cap. “Diabetes affects more than 450,000 Oklahomans, and nearly half of those have Type 1 diabetes and are dependent on insulin,” state Sen. Frank Simpson, R-Springer, said in a news release. “For many diabetics, having access to affordable insulin can literally mean the difference between life and death, avoiding amputations, blindness or other serious medical problems. Ever-increasing prices, however, are forcing many to ration or skip their insulin to pay for groceries and utilities, which is very dangerous. This bill is a step in the right direction in making insulin more affordable and helping improve the quality of life for Oklahoma’s diabetics.”